Customer Communications
Customer Communications include the latest customer letters and updates regarding Hospira products. These documents are organized in date descending order. Specific Clinical Bulletins can be accessed separately. For additional information, please refer to specific contact information in the individual release or, for general inquiries, contact Hospira.
Documents are offered in PDF format for your convenience. PDF documents require Adobe Acrobat Reader to view and print. If you do not have Adobe Acrobat Reader, you can download the free software here.
- Urgent Drug Recall – Diazepam Injection – Letter May 16, 2013
- Updated – Important Device Information – GemStar™ Infusion System Battery Leakage – Letter May 14, 2013
- Press Release – Recalls of Gemstar Infusion System to Address Battery Issues – 5/13/13
- Urgent Drug Recall – Gentamicin Sulfate Injection – Letter May 2, 2013
- Urgent Drug Recall – Dobutamine in 5% Dextrose Injection – Letter April 30, 2013
- Press Release Sodium Chloride – Particulate 100mL Flexible Container – April 26, 2013
- Urgent Drug Recall: Propofol Injectable Emulsion, 1%, 200 mg/20mL (10 mg/mL) – Letter April 8, 2013
- Urgent Drug Recall: Sodium Chloride inj, Particulate – Letter April 3, 2013
- Important Safety Information – Blood Sets – Letter April 1, 2013
- Press Release Sodium Chloride Brass Particulate 1000mL Flexible Container – Letter March 29, 2013
- Urgent Drug Recall – Diazepam Injection – Letter March 29,2013
- Urgent Drug Recall – (Expanded) Sodium Acetate Injection – Letter March 27, 2013
- GemStar™: 3/21/13 Summary of Field Corrections Issued and Information for Release of Medically Necessary Devices
- LifeCare PCA™: 3/21/13 Summary of Field Corrections Issued and Information for Release of Medically Necessary Devices
- Urgent Device Field Correction – GemStar™ Infusion System – Backward Motor Movement – Letter March 21, 2013
- Important Device Information – GemStar™ Infusion System Battery Leakage – Letter March 18, 2013
- Urgent Device Field Correction – GemStar™ Infusion System – Lithium Battery Low Voltage – Letter March 18, 2013
- Urgent Device Field Correction – GemStar™ Infusion System – Pressure Sensor Calibration Drift – Letter March 15, 2013
- Symbiq™: 2/28/13 Summary of Field Corrections Issued and Information for Release of Medically Necessary Devices
- Plum™ A+/A+3: 2/28/13 Summary of Field Corrections Issued and Information for Release of Medically Necessary Devices
- Important Device Information: LifeCare various PCA pumps – Letter 3/8/13
- Urgent Device Field Correction: LifeCare PCA™ 3 – Letter 3/8/13
- Market Withdrawal: 0.9% Sodium Chloride 1000 mL – Letter 3/7/13
- Hospira Announcement: Market Withdrawal of 0.9% Sodium Chloride 1000mL – 3/5/13
- Urgent Device Field Correction – Plum™ A+/A+3 Infusers, Battery Not Fully Recharging – Letter March 1, 2013
- Important Product Information – Aminosyn™ and Aminosyn II™ – Letter Feb. 28, 2013
- Urgent Device Field Correction – LifeCare PCA, Door Tampering – Letter Feb. 27, 2013
- Urgent Drug Recall – Diazepam, Furosemide, Quelicin – Letter Feb. 26, 2013
- Urgent Drug Recall: Preservative Free Morphine Sulfate – Letter 2/25/2013
- Urgent Drug Recall: Propofol Injectable Emulsion – Letter 2/25/2013
- Urgent Device Recall – Minibore Extension Set, 59 inch with Spin Lock Collar – Letter Feb. 19, 2013
- Urgent Drug Recall – 0.9% Sodium Chloride Injection, USP, 50 mL – Letter Feb. 18, 2013
- Urgent Drug Recall – Metronidazole Injection, USP, 500 mg (5 mg/mL), 100 mL – Letter Feb. 15, 2013
- Urgent Drug Recall – 0.9% Sodium Chloride Irrigation, USP, 3000 mL – Letter Feb. 12, 2013
- Urgent Device Field Correction – All Plum A+™ Infusers – Fluid Shield Diaphragm – Letter Feb. 6, 2013
- Urgent Device Field Correction – All Plum A+™ Infusers – Fluid Shield Fluid Ingress – Letter Feb. 6, 2013
- Urgent Device Field Correction – Symbiq™ Infusers – Backup Battery Failure – Letter Feb. 5, 2013
- Urgent Device Recall – Symbiq™ Infusers – SOM2 White Screen – Letter Feb. 5, 2013
- Urgent Device Field Correction: ALL PLUM A+™ Infusers – Distal Occlusion Pressure Sensor Drift – Letter Feb. 5, 2013
- Urgent Device Field Correction: Symbiq™ Infusers Alarms – Letter Feb. 4, 2013
- Urgent Device Field Correction: Symbiq™ Infusers – Letter Feb. 4, 2013
- Updated – Urgent Device Field Correction: ALL Plum A+™ Family of Infusers – Letter Feb. 4, 2013
- Urgent Device Field Correction - Symbiq™ Infuser – Letter Feb. 4, 2013
- Urgent Device Field Correction: ALL PLUM™ A+/A+3 Family of Infusers – Letter 2/1/2013
- Device Correction: Update – LifeCare PCA – Letter 2/1/2013
- Urgent Drug Recall: Lactated Ringers & 5% Dextrose Inj., 1000mL – Letter 1/31/2013
- Urgent Drug Recall: Furosemide Inj., USP., 4 mL Single-dose Vial – Letter 1/31/2013
- Press Release Lactated Ringer’s and 5% Dextrose Injection Recall – 1/25/2013
- Urgent Drug Recall - (Expanded) Propofol Inj. Emulsion - Letter 1/21/13
- Urgent Drug Recall 0.9% Sodium Chloride Inj., USP, 100 mL - 1/8/2013
- Press Release Carboplatin Injection Recall – 12/14/2012
- Urgent Device Field Correction – All Plum A+ Family of Infusers Door Roller – Letter 12/7/2012
- Important Safety Information Re: Flexible Containers: Lot Numbers & Expiration Dates, Embossed With No Ink – Letter 11/30/12
- Urgent UPDATED Device Correction Letter - Symbiq™ 16026 and 16027 One and Two Channel Infusers – Letter 11/28/12
- Urgent Drug Recall, Nalbuphine HCl Injection - 11/21/2012
- Important Safety Information Re: Epinephrine Inj., USP, 1:1000 (1mg/mL) - 11/21/2012
- Urgent Drug Recall, 1% Lidocaine HCl Inj., USP - 11/19/2012
- Urgent Drug Recall, Propofol Inj. Emulsion, 1%, visible particulate - 11/15/12
- Urgent Drug Recall, Propofol Inj. Emulsion, 1%, particles embedded in glass - 11/15/12
- Urgent Drug Recall, Carboplatin Inj., 45 mL, 60 mL, Multi Dose Vial - 11/08/12
- Urgent Drug Recall, Epinephrine Inj., USP 1:1000 (1mg/mL) - 11/09/12
- Press Release Symbiq Infusion Systems Class I Recall - 10/29/12
- Urgent Device Field Correction – Plum A+ Single Channel Infusers, Volume Knob - 10/26/12
- Hextend®, 500 mL - Recall 10/22/12
- 0.9% Sodium Chloride Irrigation, USP, 3000 mL – Market Withdrawal 10/12/12
- Lactated Ringers and 5% Dextrose Inj., USP, 1000 mL – Recall 10/12/12
- Hospira Market Withdrawal 0.9% Sodium Chloride Irrigation
- Lactated Ringer’s and 5% Dextrose Recall Press Release
- Hospira Efforts to Recover Stolen Hydromorphone HCl
- Urgent Device Field Correction – Update, Gemstar™ Docking Station – Letter 9/26/12
- 0.9% Sodium Chloride Injection, USP, Flush Syringe – Recall 9/17/2012
- 0.9% Sodium Chloride Injection, USP, 100 mL – Recall 8/31/12
- Urgent Device Correction Letter - Symbiq™ 16026 and 16027 One and Two Channel Infusers – Letter 8/29/12
- Propofol Injectable Emulsion, 1%, 20 mL, 50 mL and 100 mL – Recall 8/29/12
- Empty Evacuated Containers, 250 mL and 1000 mL – Recall 8/28/12
- Important Device Correction – LifeCare™ PCA Infusion System, Letter dated 8/20/2012
- Hydromorphone HCl Inj., USP, 2mg/mL (C-II) 1 mL fill in 2.5 mL Carpuject – Recall 8/20/12
- Expanded Recall of flexible containers 8-16-12
- Propofol Inj. Emulsion, Recall: 8-3-12
- Urgent Device Field Correction – "Sterile Empty Vial for use with Hospira PCA Pump" Letter: 8-3-12
- Important Safety Information Regarding Flexible IV Containers - Letter- 7/19/2012
- 4% Lidocaine LTA 360Kit, Information letter regarding appropriate use - 7/18/2012
- Expanded Flexible Plastic Containers, PVC/VisIV™, Recall – 7/19/2012
- 100 mL Burette Set, Convertible Pin, 77 inch – Recall 7/13/2012
- Carboplatin Inj. Recall 7/2/12
- Carboplatin, Cytarabine, Methotrexate and Paclitaxel glass defect Recall 6/27/12
- Propofol Inj. Emulsion, 1%, 1 g/100 mL, Recall 5/25/2012
- Hospira Announces Important Safety Information Regarding Carpuject™ Syringe System and the Potential for Overfill, 5/18/12
- List of Impacted Carpuject™ Syringes and Product Photos, 5/18/12
- Hydromorphone HCl Inj., 1 mL fill in 2.5 mL Carpuject Recall 5/15/12
- 0.9% Sodium Chloride Inj., VisIV™ Container Recall – 5/4/12
- Lifeshield™ Primary PlumSet™, Clave™ Port, Recall 4/25/12
- Customer Letter for Aminosyn II Color, 4-18-12
- Morphine Sulfate Injection 4mg/mL, Recall 4-18-12
- Propofol Injectable Emulsion, 1%, Recall 4-11-12
- Mag. Sulphate in Water for Inj., 40mg/mL, 50mL Flexible Container Recall 4-5-12
- Gemstar™ Bolus Cord Field Correction Recall 3/28/2012
- 0.9% Sodium Chloride Irrigation, 3000mL - Recall 2/13/2012
- 0.9% Sodium Chloride Flush Syringe Recall – Expanded 1-31-12
- 0.9% NaCl, 250mL; 0.4% Lidocaine HCI and 5% Dextrose, 250mL - Recall 1/20/2012
- Quelicin™, 1000 mg, 10mL Fliptop Vial, Recall 1/17/2012
- Blood Set, 200 Micron Filter, Recall 1/12/2012
- 0.9% Sodium Chloride Inj., 500mL, OOS pH, Recall 12/9/2011
- 0.9% Sodium Chloride Flush Syringe Recall
- Lactated Ringer's Injection, USP recall
- 150 mL Burette Set Recall Letter
- AMENDED Recall Letter: Piperacillin & Tazobactam for Inj
- Piperacillin & Tazobactam for Inj. Recall
- Tazicef Recall Letter
- Plum A+ Regulator Closer - Reboot Recall Letter
- Furosemide Inj., USP, 100 mg recall notification
- 5% Dextrose Inj. USP Recall 8-18-11
- 0.9% Sodium Chloride Inj. Recall 8-11-11
- Pediatric Atropine Sulfate Inj. Recall
- Gemstar™ Docking Station Device Field Correction
- iSecure Syringe products recall notification
- Baxa Exacta-Mix® EVA Container, 2000mL
- 0.9% Sodium Chloride Inj., USP ADD-Vantage 5/6/11
- Hospira sets/detached air filter
- 0.9% Sodium Chloride Inj., USP(Port Leak)
- 0.9% Sodium Chloride Injection, USP Expanded
- Gemstar SP Infusion Suite Database
- Lorazepam Injection, USP 2mg/mL
- 0.9% Sodium Chloride Injection USP
- Plum XL Recall: No Audible Alarm
- Plum A+ Recall: No Audible Alarm
- Symbiq Medical Device Recall - Power Cords
- Symbiq MR1 Motor Encoder Recall - Update
- Symbiq Microbore Administration Set Recall Notification
- Symbiq Microbore Administration Set Recall Expansion
- Symbiq Motor/Pole Clamp Recall Notification
- Symbiq Unrestricted Flow Recall Notification
- GemStar™ Pump Set Device Recall
- Symbiq Medical Device Recall